CStone Pharmaceuticals (2616.HK)

HKD 2.39

(-6.64%)

Operating Expenses Summary of CStone Pharmaceuticals

CStone Pharmaceuticals's latest annual operating expenses in 2023 was 304.29 Million CNY , down -25.19% from previous year.
CStone Pharmaceuticals's latest quarterly operating expenses in 2024 Q1 was 87.84 Million CNY , down -65.03% from previous quarter.
CStone Pharmaceuticals reported a annual operating expenses of 1.18 Billion CNY in annual operating expenses 2022, down -38.77% from previous year.
CStone Pharmaceuticals reported a annual operating expenses of 1.93 Billion CNY in annual operating expenses 2021, up 3.68% from previous year.
CStone Pharmaceuticals reported a quarterly operating expenses of 87.84 Million CNY for 2024 Q1, down -65.03% from previous quarter.
CStone Pharmaceuticals reported a quarterly operating expenses of 884.14 Million CNY for 2023 FY, down -25.19% from previous quarter.

Annual Operating Expenses Chart of CStone Pharmaceuticals (2023 - 2016)

Historical Annual Operating Expenses of CStone Pharmaceuticals (2023 - 2016)

Year	Operating Expenses	Operating Expenses Growth
2023	304.29 Million CNY	-25.19%
2022	1.18 Billion CNY	-38.77%
2021	1.93 Billion CNY	3.68%
2020	1.86 Billion CNY	7.12%
2019	1.73 Billion CNY	64.11%
2018	1.05 Billion CNY	336.78%
2017	242.47 Million CNY	-7.51%
2016	262.17 Million CNY	0.0%

Year	Operating Expenses	Operating Expenses Growth
2024 Q2	87.84 Million CNY	0.0%
2024 Q1	87.84 Million CNY	-65.03%
2023 FY	884.14 Million CNY	-25.19%
2023 Q1	186.08 Million CNY	-43.01%
2023 Q3	156.21 Million CNY	-16.06%
2023 Q2	186.08 Million CNY	0.0%
2023 Q4	251.22 Million CNY	60.83%
2022 Q4	326.5 Million CNY	0.0%
2022 FY	1.18 Billion CNY	-38.77%
2022 Q3	326.5 Million CNY	23.39%
2022 Q2	264.61 Million CNY	0.0%
2022 Q1	264.61 Million CNY	-57.24%
2021 Q4	618.83 Million CNY	0.0%
2021 Q3	618.83 Million CNY	49.68%
2021 FY	1.93 Billion CNY	3.68%
2021 Q1	413.44 Million CNY	-38.74%
2021 Q2	413.44 Million CNY	0.0%
2020 Q2	345.72 Million CNY	0.0%
2020 Q3	674.9 Million CNY	95.22%
2020 FY	1.86 Billion CNY	7.12%
2020 Q4	674.9 Million CNY	0.0%
2020 Q1	345.72 Million CNY	-38.06%
2019 Q3	558.13 Million CNY	-11.35%
2019 FY	1.73 Billion CNY	64.11%
2019 Q4	558.13 Million CNY	0.0%
2019 Q1	629.57 Million CNY	164.13%
2019 Q2	629.57 Million CNY	0.0%
2018 Q1	374.12 Million CNY	660.79%
2018 FY	1.05 Billion CNY	336.78%
2018 Q4	238.35 Million CNY	-14.09%
2018 Q3	277.46 Million CNY	-25.84%
2018 Q2	374.12 Million CNY	0.0%
2017 FY	242.47 Million CNY	-7.51%
2017 Q4	49.17 Million CNY	0.0%
2016 FY	262.17 Million CNY	0.0%

Peer Operating Expenses Comparison of CStone Pharmaceuticals

Name	Operating Expenses	Operating Expenses Difference
Uni-Bio Science Group Limited	325.05 Million HKD	6.385%
CK Life Sciences Int'l., (Holdings) Inc.	739.25 Million HKD	58.838%